- Home
- ACIU vs BKTI Comparison
ACIU vs BKTI Comparison
Compare ACIU & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | BKTI |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.6M | 277.1M |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ACIU | BKTI |
|---|---|---|
| Price | $2.42 | $66.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.57 | N/A |
| AVG Volume (30 Days) | ★ 182.8K | 41.0K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.89 |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $74,094,000.00 |
| Revenue This Year | $422.39 | $4.72 |
| Revenue Next Year | $377.85 | $14.74 |
| P/E Ratio | ★ N/A | $45.59 |
| Revenue Growth | N/A | ★ 45.42 |
| 52 Week Low | $2.10 | $60.00 |
| 52 Week High | $4.00 | $104.55 |
Technical Indicators
Market Signals| Indicator | ACIU | BKTI |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 37.98 |
| Support Level | $2.40 | $64.55 |
| Resistance Level | $2.68 | $76.13 |
| Average True Range (ATR) | 0.09 | 2.50 |
| MACD | -0.00 | -0.44 |
| Stochastic Oscillator | 18.92 | 19.79 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BKTI BK Technologies Corporation
BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.